Indications and uses
For clearing the nasal cavities and the removal of the unpleasant mucus For nasal irrigation
For clearing the nasal cavities and the removal of the unpleasant mucus For nasal irrigation
* Apply 1-4 sprayings into each nostril up to 4 times a day * As a prevention use once a day with 2 sprayings
lodine (0.002%)
Sodium Chloride (0.9%)
lodine (0.002%) Antiseptic
Sodium Chloride (0.9%) Nasal Decongestant
* Apply 1-4 sprayings into each nostril up to 4 times a day
* As a prevention use once a day with 2 sprayings
Keep out of reach of children
* Use only as directed
* The use of the dispenser by more than 1 person may spread infection
* Store at room temperature between 68 and 77°F (20-25 °C)
NDC: 80897-030-35
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 2566829 | iodine 0.002 % / sodium chloride 0.9 % Nasal Spray | PSN | 2 |
| 2566829 | iodine 0.02 MG/ML / sodium chloride 9 MG/ML Nasal Spray | SCD | 2 |
| 2566829 | iodine 0.002 % / sodium chloride 0.9 % Nasal Spray | SY | 2 |
| 2566829 | iodine 0.02 MG/ML / NaCl 9 MG/ML Nasal Spray | SY | 2 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 80897-030-35 | 2025-01-30 | C162847 | 48780-1 | 2cef2736-98a6-d83d-e063-dadaa90ab31f | Incarvexx Essential Nasal Spray |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80897-030-35 | Incarvexx Essential | 35 mL in 1 BOTTLE, SPRAY | SPRAY | 35 | 2 | |
| 80897-030-35 | Incarvexx Essential | 1 in 1 CARTON | SPRAY | 1 | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 80897-030 | 80897-030-35 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| IODINE | 9679TC07X4 | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f1f0be1e-39c3-a6d4-e053-2a95a90af0b6 | c55e3b82-f8d9-1934-e053-2995a90a7511 | 2023-01-10 | Warnings | f1f0be1e-39c3-a6d4-e053-2a95a90af0b6 c55e3b82-f8d9-1934-e053-2995a90a7511 |
Adverse event summaries are temporarily unavailable. Other product information remains available.